Shinpoong Pharmaceutical Co.,Ltd Stock price

Equities

A019170

KR7019170000

Pharmaceuticals

End-of-day quote Korea S.E. 07:00:00 2024-03-27 pm EDT 5-day change 1st Jan Change
15,820 KRW -2.04% Intraday chart for Shinpoong Pharmaceutical Co.,Ltd +24.86% +17.01%
Sales 2021 189B 140M Sales 2022 209B 155M Capitalization 1,125B 835M
Net income 2021 -11.58B -8.6M Net income 2022 -35.38B -26.25M EV / Sales 2021 8.26 x
Net cash position 2021 91.52B 67.91M Net cash position 2022 53.99B 40.06M EV / Sales 2022 5.12 x
P/E ratio 2021
-147 x
P/E ratio 2022
-31.9 x
Employees 828
Yield 2021 *
-
Yield 2022
-
Free-Float 58.9%
More Fundamentals * Assessed data
Dynamic Chart
1 day-2.04%
1 week+24.86%
Current month+31.83%
1 month+30.96%
3 months+17.01%
6 months+2.73%
Current year+17.01%
More quotes
1 week
15 750.00
Extreme 15750
19 850.00
1 month
11 600.00
Extreme 11600
19 850.00
Current year
11 180.00
Extreme 11180
19 850.00
1 year
9 560.00
Extreme 9560
22 950.00
3 years
9 560.00
Extreme 9560
111 000.00
5 years
4 940.00
Extreme 4940
214 000.00
10 years
3 653.82
Extreme 3653.818
214 000.00
More quotes
Managers TitleAgeSince
Chief Executive Officer 67 14-03-20
Director of Finance/CFO 59 -
Chief Tech/Sci/R&D Officer 51 -
Members of the board TitleAgeSince
Director/Board Member 53 13-03-28
Chief Executive Officer 67 14-03-20
Director/Board Member 52 20-03-26
More insiders
Date Price Change Volume
24-03-28 15,820 -2.04% 2,323,122
24-03-27 16,150 -3.98% 1,698,043
24-03-26 16,820 -8.19% 4,070,340
24-03-25 18,320 +12.67% 10,579,860
24-03-22 16,260 +28.33% 10,230,830

End-of-day quote Korea S.E., March 27, 2024

More quotes
Shin Pooong Pharm., Co. Ltd is a Korea-based company mainly engaged in the manufacture of pharmaceuticals. The Company's product portfolio consists of antibiotics, cardiovascular drugs, anti-cancer drugs, psychoneurotic drugs, antirheumatic drugs, antidiabetics, antifungal agents, antihistamines, antiviral agents, benign prostatic hyperplasia (BPH) drugs and trichogens. The Company also provides active pharmaceutical ingredients (APIs) synthesized by the Company, including non-steroidal anti-inflammatory drugs (NSAIDs), cardiovascular drugs, anti-ulcer drugs, respiratory drugs, antispasmodics drugs and others. The Company distributes its products within domestic market and to overseas markets.
More about the company
Trading Rating
Investor Rating
ESG Refinitiv
D
More Ratings
  1. Stock
  2. Equities
  3. Stock Shinpoong Pharmaceutical Co.,Ltd - Korea S.E.